These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6172388)

  • 41. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.
    Hammerstrøm J
    Scand J Immunol; 1979; 10(6):575-84. PubMed ID: 396667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells.
    Haskill S; Koren H; Becker S; Fowler W; Walton L
    Br J Cancer; 1982 May; 45(5):737-46. PubMed ID: 6177328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
    Allavena P; Peccatori F; Maggioni D; Erroi A; Sironi M; Colombo N; Lissoni A; Galazka A; Meiers W; Mangioni C
    Cancer Res; 1990 Nov; 50(22):7318-23. PubMed ID: 2121337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of natural killer activity by human bronchoalveolar macrophages.
    Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
    J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumoricidal activity of human monocytes activated in vitro by free and liposome-encapsulated human lymphokines.
    Kleinerman ES; Schroit AJ; Fogler WE; Fidler IJ
    J Clin Invest; 1983 Jul; 72(1):304-15. PubMed ID: 6348087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural cytotoxicity of mouse monocytes and macrophages.
    Tagliabue A; Mantovani A; Kilgallen M; Herberman RB; McCoy JL
    J Immunol; 1979 Jun; 122(6):2363-70. PubMed ID: 221585
    [No Abstract]   [Full Text] [Related]  

  • 49. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
    Celada A; Gray PW; Rinderknecht E; Schreiber RD
    J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Macrophage depletion test in guinea pigs].
    Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):105-8. PubMed ID: 135493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
    Gordon IO; Freedman RS
    Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
    Melioli G; Ferrari I; Casartelli G; Ragni N
    Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural immunity against ovarian tumors.
    Lotzová E; Savary CA; Freedman R; Bowen JM
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):269-75. PubMed ID: 3491727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.
    Epstein LB; Marcus SG
    Cancer Chemother Pharmacol; 1981; 6(3):273-7. PubMed ID: 6172214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.
    Lee KC; Wong M; McIntyre D
    J Immunol; 1981 Jun; 126(6):2474-9. PubMed ID: 6971902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure and function of human effusion macrophages from patients with malignant and benign disease. 1. Isolation, morphology, proliferation and phagocytosis.
    Hammerstrøm J
    Acta Pathol Microbiol Scand C; 1980 Aug; 88(4):191-200. PubMed ID: 7004080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.